Key facts
| Recalling firm | Medtronic Xomed, Inc. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM 4.0, REF: NIM4CM01; CONSOLE NIM4CM01RF NIM 4.0 REFURBISHED, REF: NIM4CM01RF; PATIENT INTERFACE NIM4CPB1 NIM 4.0, REF: NIM4CPB1; PATIENT INTFC NIM4CPB1RF NIM 4.0 REFURB, REF: NIM4CPB1RF; SOFTWARE NIM4SWU143 UPGRADE V1.4.3, REF: NIM4SWU143; SOFTWARE NIM4SWU154 UPGRADE V1.5.4, REF: NIM4SWU154; SOFTWARE NIM4SWU164 UPGRADE V1.6.4, REF: NIM4SWU164 |
| Classification | Class II |
| Recall number | Z-1623-2025 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Nerve Monitoring System with certain software versions has potential for increased stimulus artifact, which may require troubleshooting, and may lead to procedure delay, extubation, and medical intervention. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM 4.0, REF: NIM4CM01; CONSOLE NIM4CM01RF NIM 4.0 REFURBISHED, REF: NIM4CM01RF; PATIENT INTERFACE NIM4CPB1 NIM 4.0, REF: NIM4CPB1; PATIENT INTFC NIM4CPB1RF NIM 4.0 REFURB, REF: NIM4CPB1RF; SOFTWARE NIM4SWU143 UPGRADE V1.4.3, REF: NIM4SWU143; SOFTWARE NIM4SWU154 UPGRADE V1.5.4, REF: NIM4SWU154; SOFTWARE NIM4SWU164 UPGRADE V1.6.4, REF: NIM4SWU164 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic Xomed, Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic Xomed, Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic Xomed, Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Medtronic Xomed, Inc.’s FDA history
Argus HQ has recorded 5 total FDA actions tied to Medtronic Xomed, Inc.: 0 warning letters, 5 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- Who should I contact about this recall?
- Contact Medtronic Xomed, Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
- Has Medtronic Xomed, Inc. had other FDA recalls or enforcement actions?
- Yes. Argus HQ has recorded 5 total FDA actions tied to Medtronic Xomed, Inc., including 5 recalls and 0 warning letters.
- What is the FDA recall number for this event?
- FDA recall number Z-1623-2025.
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Medtronic Xomed, Inc.- Recall: Medtronic Xomed, Inc. — Class II recall: IPC Powerease System REF 2300000 UDI-DI: 00613994448705 00643169406834. Th… →
- Recall: Medtronic Xomed, Inc. — Class II recall: Medtronic ENT Ultra Round Steel Cutting Bur, Model Number REF 31313069 →
- Recall: Medtronic Xomed, Inc. — Class I recall: NIM Vital Nerve Monitoring systems (all serial numbers manufactured) with NIM Vi… →
- Recall: Medtronic Xomed, Inc. — Class II recall: NIM TriVantage EMG Endotracheal Tubes, Model (REF) Numbers and sizes: a) 822970… →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2025). FDA Class II Recall: NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM… by Medtronic Xomed, Inc.. Digital Empire LLC. Retrieved from https://argushq.ai/recall/medtronic-xomed-z-1623-2025-2025-04-30
"FDA Class II Recall: NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM… by Medtronic Xomed, Inc.." Argus HQ Research, Digital Empire LLC, 2025, argushq.ai/recall/medtronic-xomed-z-1623-2025-2025-04-30.
Argus HQ Research. "FDA Class II Recall: NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM… by Medtronic Xomed, Inc.." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/medtronic-xomed-z-1623-2025-2025-04-30.
@misc{argushq_argushq_ai_recall_medtronic_xomed_z_1623_2025_2025_04_30_2025,
title = {FDA Class II Recall: NIM Vital Nerve Monitoring System: CONSOLE NIM4CM01 NIM… by Medtronic Xomed, Inc.},
author = {{Argus HQ Research}},
year = {2025},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/medtronic-xomed-z-1623-2025-2025-04-30},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗

